Gemma L Kelly

16PUBLICATIONS
68CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer diagnosisHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 21, 2025
Genome-wide in vivo CRISPR screens identify GATOR1 complex as a tumor suppressor in Myc-driven lymphoma.

Margaret A Potts, Shinsuke Mizutani, Yexuan Deng

|Nov 20, 2024
Breathing new insights into the role of mutant p53 in lung cancer.

Tianwei Chen, Lauren M Ashwood, Olga Kondrashova

|Aug 19, 2024
Mouse models to investigate in situ cell fate decisions induced by p53.

Elizabeth Lieschke, Annabella F Thomas, Andrew Kueh

|Apr 04, 2024
Cancer Hallmarks: Piecing the Puzzle Together.

Maria P Alcolea, Direna Alonso-Curbelo, Chiara Ambrogio

|Dec 14, 2023
Genome-wide CRISPR screening identifies a role for ARRDC3 in TRP53-mediated responses.

John E La Marca, Brandon J Aubrey, Bruce Yang

|Oct 25, 2023
Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer Cells.

Zilu Wang, Matteo Burigotto, Sabrina Ghetti

Pageof 3

Frequent Collaborators

15 joint publications

Andreas Strasser

8 joint publications

Sarah T Diepstraten

7 joint publications

Marco J Herold

5 joint publications

Elizabeth Lieschke